BioPharma Dive - Latest News

Draig, a brain drug startup, debuts with $140M to treat depression

The funds will support Phase 2 testing of a drug the company believes to be able to safety home in on AMPA receptors, an emerging but unproven depression target.

Jun 18, 2025 - 17:40
 0
Draig, a brain drug startup, debuts with $140M to treat depression

The funds will support Phase 2 testing of a drug the company believes to be able to safety home in on AMPA receptors, an emerging but unproven depression target.

Read More

Tags:

Previous Article

Scholar Rock drug preserves muscle in obesity trial

Next Article

STAT+: Vaccine advisers to consider MMRV vaccines, ‘thimerosal containing’ flu s...

Related Posts

FDA meeting gives window into gene therapy field’s angst

FDA meeting gives window into gene therapy field’s angst

Jun 6, 2025  0

GSK to buy liver disease drug for $1.2B

GSK to buy liver disease drug for $1.2B

May 14, 2025  0

A vision for the future of lung cancer treatment

A vision for the future of lung cancer treatment

Jun 2, 2025  0